Cogent Biosciences, Inc.

Feb 18, 2021

Cogent Biosciences to Present at Virtual 10th Annual SVB Leerlink Global Healthcare Conference 2021

Feb 11, 2021

Cogent Biosciences to Present at LifeSci Partners Virtual Precision Oncology Day 2021

Dec 04, 2020

Cogent Biosciences Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriter's Option to Purchase Additional Shares

Dec 01, 2020

Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock

Nov 20, 2020

Cogent Biosciences to Participate in 3rd Annual Evercore ISI HealthCONx Virtual Conference

Nov 18, 2020

Cogent Biosciences Announces Final Results from PLX9486 Phase 1/2 Study in Advanced GIST Patients at CTOS 2020

Nov 09, 2020

Cogent Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Updates

Nov 05, 2020

Cogent Biosciences to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference

Oct 26, 2020

Cogent Biosciences Appoints Andrew Robbins as Chief Executive Officer

Oct 05, 2020

Unum Therapeutics Announces Company Name Change to Cogent Biosciences, Highlights Recent Scientific and Operational Progress